Four Leading Scientists Join Inocucor Scientific Advisory Board

DENVER, Feb. 20, 2018—Four scientists with combined expertise in fermentation science, microbial profiling in humans and the movement of bacteria in soil have joined the Scientific Advisory Board for Inocucor, an agri-tech company that produces biological crop inputs for row crops and high-value produce. “This esteemed team of scientists will actively participate in formulating the company’s R&D activities at its Denver and Montreal labs,” said Inocucor’s Executive V.P. for R&D and Chief Technical Officer Shawn Semones, who joined Inocucor last November after a long career at Novozymes Biologicals, Inc. The board will be led by Jonathan Leder, Ph.D., recently retired Director of Novozymes Bi

Inocucor Raises $9.5M in Series B 2nd Close Led by Pontifax AgTech, Raising Total Financing to $38.5

DENVER, Jan. 8, 2018 /PRNewswire/ -- Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, announced the $9.5 million USD ($12.1M CAD) second close of its Series B financing round. Funds raised to date in its Series B round now total $38.5 million USD ($50.9 million CAD). The round was led by Pontifax AgTech, a leading growth capital investor in the global food and agriculture sector. Other participants in the second Series B round include existing investors Cycle Capital Management (Montreal), Desjardins Innovatech (Montreal) and Cairn Investments (Denver). Inocucor's first Series B equity financing of $29 million USD ($38.8 million C

Recent Posts

2025 S Westgate Ave, First Floor, Los Angeles, CA 90025  |  323-306-9970 

© 2014 Pontifax Global Food and Agriculture Technology Fund LP

  • LinkedIn Social Icon